Cancer recurrences and second primary cancers after use of antihistamines or antidepressants

Clinical Pharmacology and Therapeutics

Volumn 63, Issue 5, 1998, Pages 594-599

  Weiss, Sheila R ^b   McFarland, Bentson H ^a   Burkhart, Greg A ^b   Ho, Peter T C ^b  

^a KAISER PERMANENTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; HISTAMINE H1 RECEPTOR ANTAGONIST;

ADULT; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER RISK; COLON CARCINOMA; CONTROLLED STUDY; FEMALE; FOOD AND DRUG ADMINISTRATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; PHARMACOEPIDEMIOLOGY; PRIORITY JOURNAL; SECOND CANCER; AGED; BREAST TUMOR; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; COLON TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; REGISTER; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; ANTIDEPRESSIVE AGENTS; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COHORT STUDIES; COLONIC NEOPLASMS; COMBINED MODALITY THERAPY; FEMALE; HISTAMINE H1 ANTAGONISTS; HUMANS; MALE; MELANOMA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PHARMACOEPIDEMIOLOGY; REGISTRIES;

EID: 0031596080     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(98)90110-2     Document Type: Article

References (14)

1. Brandes LJ, Arron RJ, Bogdanovic RP, Tong J, Zaborniak CL, Hogg GR, et al. Stimulation of malignant growth in rodents by antidepressant drugs at clinically relevant doses. Cancer Res 1992;52:3796-800.
2. 1-antihistamines: predictive in vitro correlates. J Natl Cancer Inst 1994;18:770-5.
3. Hilakivi-Clarke L, Wright A, Lippman ME. Neonatal antidepressant treatment promotes DMBA-induced mammary tumor growth [abstract]. Proc Am Assoc Cancer Res 1993;34:184.
4. Iishi H, Tatsuta M, Baba M, Taniguchi H. Enhancement by the tricyclic antidepressant, desipramine, of experimental carcinogenesis in rat colon induced by azoxymethane. Carcinogenesis 1993;14:1837-40.
5. Tutton PJ, Barkla DH. Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas. Br J Cancer 1982;46:260-5.
6. Bendele RA, Adams ER, Hoffman WP, Gries CL, Morton DM. Carcinogenicity studies of fluoxetine hydrochloride in rats andmice. Cancer Res 1992;52:6931-5.
7. Miller LG. Antidepressants and cancer: cause for concern? [editorial]. J Clin Psychopharmacol 1993;13:1-2.
8. Breggin PR, Breggin GR. Talking back to Prozac. New York: St. Martin's Press; 1994. p. 89-90.
9. Nemecek S. Backfire: could Prozac and Elavil promote tumor growth? Sci Am 1994;271:22-3.
10. Friedman GD. Re: Depression, antidepressant medication, and cancer [letter]. Am J Epidemiol 1992;136:1415-6.
11. Steingart AB, Cotterchio M. Do antidepressants cause, promote, or inhibit cancers? J Clin Epidemiol 1995;48:1407-12.
12. Greenlick MR, Freeborn DK, Pope CR. Health care research in an HMO: two decades of discovery. Baltimore: Johns Hopkins University Press; 1988.
13. Kaiser Permanente Regional Cancer Committee. Annual Cancer Report, 1995. Portland: Kaiser Permanente, Northwest Region; 1996.
14. McFarland BH. Automated pharmacy databases and behavioral health care quality assurance. Eval Rev 1997;21:371-8.